WVE (STOCKS)
Wave Life Sciences Ltd. Ordinary Shares
$6.010000
+0.140000 (+2.39%)
Prev close: $5.870000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Paul B. Bolno
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,153.45M
- Employees
- 288
- P/E (TTM)
- -5.69
- P/B (TTM)
- 2.26
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
13
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.13 | $-0.33 | +0.2011 | +60.74% |
|
Dec 2025 (Q4)
|
$-0.30 | $-0.27 | -0.0272 | -9.97% |
|
Sep 2025 (Q3)
|
$-0.32 | $-0.30 | -0.0187 | -6.21% |
|
Jun 2025 (Q2)
|
$-0.31 | $-0.29 | -0.0165 | -5.62% |
Financial Statements
| Revenues | $71.80M |
| Benefits Costs and Expenses | $255.39M |
| Costs And Expenses | $250.17M |
| Nonoperating Income/Loss | $13.29M |
| Operating Expenses | $268.68M |
| Research and Development | $189.60M |
| Other Operating Expenses | $79.08M |
| Operating Income/Loss | -$196.88M |
| Income/Loss From Continuing Operations After Tax | -$183.59M |
| Income/Loss From Continuing Operations Before Tax | -$183.59M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$183.59M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$183.59M |
| Net Income/Loss Available To Common Stockholders, Basic | -$183.59M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.05 |
| Diluted Earnings Per Share | -$1.05 |
| Basic Average Shares | 535,770,987 |
| Diluted Average Shares | 535,770,987 |
| Assets | $583.54M |
| Current Assets | $561.27M |
| Prepaid Expenses | $13.23M |
| Other Current Assets | $548.05M |
| Noncurrent Assets | $22.27M |
| Fixed Assets | $7.08M |
| Other Non-current Assets | $15.20M |
| Liabilities | $71.81M |
| Current Liabilities | $49.83M |
| Accounts Payable | $19.06M |
| Wages | $5.52M |
| Other Current Liabilities | $25.25M |
| Noncurrent Liabilities | $21.98M |
| Equity | $511.73M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $511.73M |
| Temporary Equity | $0.00 |
| Temporary Equity Attributable To Parent | $0.00 |
| Liabilities And Equity | $583.54M |
| Net Cash Flow From Operating Activities | -$184.01M |
| Net Cash Flow From Operating Activities, Continuing | -$184.01M |
| Net Cash Flow From Investing Activities | -$991.00K |
| Net Cash Flow From Investing Activities, Continuing | -$991.00K |
| Net Cash Flow From Financing Activities | $486.61M |
| Net Cash Flow From Financing Activities, Continuing | $486.61M |
| Net Cash Flow | $301.61M |
| Net Cash Flow, Continuing | $301.61M |
| Comprehensive Income/Loss | -$183.64M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$183.64M |
| Other Comprehensive Income/Loss | -$50.00K |